Natural products as sources of new drugs from 1981 to 2014
DJ Newman, GM Cragg - Journal of natural products, 2016 - ACS Publications
This contribution is a completely updated and expanded version of the four prior analogous
reviews that were published in this journal in 1997, 2003, 2007, and 2012. In the case of all …
reviews that were published in this journal in 1997, 2003, 2007, and 2012. In the case of all …
Kinase-targeted cancer therapies: progress, challenges and future directions
The human genome encodes 538 protein kinases that transfer a γ-phosphate group from
ATP to serine, threonine, or tyrosine residues. Many of these kinases are associated with …
ATP to serine, threonine, or tyrosine residues. Many of these kinases are associated with …
Natural products as sources of new drugs over the period 1981− 2002
DJ Newman, GM Cragg, KM Snader - Journal of natural products, 2003 - ACS Publications
This review is an updated and expanded version of a paper that was published in this
journal in 1997. The time frame has been extended in both directions to include the 22 years …
journal in 1997. The time frame has been extended in both directions to include the 22 years …
Protein kinase inhibitors: insights into drug design from structure
Protein kinases are targets for treatment of a number of diseases. This review focuses on
kinase inhibitors that are in the clinic or in clinical trials and for which structural information is …
kinase inhibitors that are in the clinic or in clinical trials and for which structural information is …
Flavonoids as prospective compounds for anti-cancer therapy
D Ravishankar, AK Rajora, F Greco… - The international journal …, 2013 - Elsevier
Flavonoids, which are polyphenolic compounds, are a class of plant secondary metabolites
possessing a broad spectrum of pharmacological activity including anti-cancer activities …
possessing a broad spectrum of pharmacological activity including anti-cancer activities …
[HTML][HTML] Tyrosine kinase–role and significance in cancer
MK Paul, AK Mukhopadhyay - International journal of medical …, 2004 - ncbi.nlm.nih.gov
Tyrosine kinases are important mediators of the signaling cascade, determining key roles in
diverse biological processes like growth, differentiation, metabolism and apoptosis in …
diverse biological processes like growth, differentiation, metabolism and apoptosis in …
Ten things you should know about protein kinases: IUPHAR R eview 14
D Fabbro, SW Cowan‐Jacob… - British journal of …, 2015 - Wiley Online Library
Many human malignancies are associated with aberrant regulation of protein or lipid
kinases due to mutations, chromosomal rearrangements and/or gene amplification. Protein …
kinases due to mutations, chromosomal rearrangements and/or gene amplification. Protein …
Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors
JJL Liao - Journal of medicinal chemistry, 2007 - ACS Publications
Protein kinases constitute one of the largest protein families in humans. 1, 2 The kinase
enzymes in this family catalyze phosphorylation of serine, threonine, or tyrosine residues …
enzymes in this family catalyze phosphorylation of serine, threonine, or tyrosine residues …
New pyrimidine and pyrazole-based compounds as potential EGFR inhibitors: Synthesis, anticancer, antimicrobial evaluation and computational studies
IMM Othman, ZM Alamshany, NY Tashkandi… - Bioorganic …, 2021 - Elsevier
This study was focused on the synthesis of new pyrimidines 4a, b, 5a, b and pyrazoles 6a, b
as ATP mimicking tyrosine kinase inhibitors of the epidermal growth factor receptor (EGFR) …
as ATP mimicking tyrosine kinase inhibitors of the epidermal growth factor receptor (EGFR) …
Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants
Background & Aims: Resistance is a major challenge in the treatment of patients with
gastrointestinal stromal tumors (GISTs). We investigated the mechanisms of resistance in …
gastrointestinal stromal tumors (GISTs). We investigated the mechanisms of resistance in …